Heyu Biological Technology Corporation (HYBT)
Heyu Biological Technology Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Xiamen, CN. The stock last traded at $0.35, down 41.67% on the session, giving a market capitalisation of $361.4M. On trailing twelve-month figures it carries a trailing P/E of 175.00, a net margin of 8.8%. Its beta of -17.89 implies it has historically moved less than the broad market.
Heyu Biological Technology Corporation, alongside its subsidiaries, focuses on the research, development, and production of healthcare equipment. A key area of its present work involves developing the Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical device intended for cancer treatment. This innovative equipment is designed to induce cold nuclear fusion via cosmic ray muons within a contained environment to combat the disease. The company, incorporated in 1987 and headquartered in Xiamen, People's Republic of China, was formerly known as Pacific WebWorks, Inc., before adopting its current name, Heyu Biological Technology Corporation, in June 2018.
Heyu Biological Technology Corporation is most often compared with the following Healthcare names: